Search results for Insulin Like Growth Factor 2 Receptor (IGF2R) Antibody

Insulin Like Growth Factor 2 Receptor (IGF2R) Antibody, Abbexa, abx104020
Polyclonal Antibody to Insulin Like Growth Factor 2 Receptor (IGF2R).
Host
Rabbit
Reactivity
Rat
Applications
WB, IHC, IF/ICC
Conjugation
Unconjugated

Insulin Like Growth Factor 2 Receptor (IGF2R) Antibody, Abbexa, abx413646
Cation-Independent Mannose-6-Phosphate Receptor (CD222) Antibody is a Mouse Monoclonal antibody against Cation-Independent Mannose-6-Phosphate Receptor (CD222).
Host
Mouse
Reactivity
Human
Applications
IF/ICC, FCM
Conjugation
Unconjugated

Insulin Like Growth Factor 2 Receptor (IGF2R) Antibody, Abbexa, abx140404
CD222 Antibody is a Mouse Monoclonal against CD222.
Host
Mouse
Reactivity
Human
Applications
WB, FCM, IP
Conjugation
Unconjugated

Insulin Like Growth Factor 2 Receptor (IGF2R) Antibody, Abbexa, abx104018
Polyclonal Antibody to Insulin Like Growth Factor 2 Receptor (IGF2R).
Host
Rabbit
Reactivity
Human
Applications
WB, IHC, IF/ICC
Conjugation
Unconjugated

Insulin Like Growth Factor 2 Receptor (IGF2R) Antibody (FITC), Abbexa, abx413648
Cation-Independent Mannose-6-Phosphate Receptor (CD222) Antibody (FITC) is a Mouse Monoclonal antibody against Cation-Independent Mannose-6-Phosphate Receptor (CD222).
Host
Mouse
Reactivity
Human
Applications
FCM
Conjugation
FITC

Insulin Like Growth Factor 2 Receptor (IGF2R) Antibody (APC), Abbexa, abx139553
CD222 Antibody is a Mouse Monoclonal against CD222.
Host
Mouse
Reactivity
Human, Monkey
Applications
FCM
Conjugation
APC

Insulin Like Growth Factor 2 Receptor (IGF2R) Antibody (PE), Abbexa, abx139552
CD222 Antibody is a Mouse Monoclonal against CD222.
Host
Mouse
Reactivity
Human, Monkey
Applications
FCM
Conjugation
PE

Insulin Like Growth Factor 2 Receptor (IGF2R) Antibody (PE), Abbexa, abx140429
CD222 Antibody (PE ) is a Mouse Monoclonal against CD222.
Host
Mouse
Reactivity
Human
Applications
FCM
Conjugation
PE
Please provide the required information below so that we can quickly source your products.
